# Syndesi Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/syndesi-therapeutics

- Industry: Biotechnology
- Headquarters: Louvain-la-Neuve, Belgium
- Website: www.syndesitherapeutics.com
- Total disclosed funding: $27M
- Latest round: Series A (Jun 26, 2020)
- Investors on record: 9

## About

Based in Belgium, and founded in 2018, Syndesi Therapeutics SA operates as a biotechnology company that develops SV2A modulators to improve cognition in diseases such as Alzheimer’s Disease, other dementias, and cognitive impairment associated with schizophrenia. In March 2022, AbbVie acquired Syndesi Therapeutics SA from Novo Holdings, Fountain Healthcare, Johnson & Johnson Innovation, etc for USD 1 billion in total deal value with USD 130 million upfront and additional contingent payments of up to USD 870 million based on the achievement of certain predetermined milestones. As of May 2023, Jonathan Savidge is the Chief Executive Officer (CEO).

Syndesi Therapeutics SA creates medications for the treatment of neurological disorders such as Alzheimer's. The company's drugs have the ability to regulate the synaptic vesicle protein, which allows neurons in the brain to communicate with one another. As a result, healthcare providers can treat these cognitive diseases effectively by utilizing the appropriate therapy provided by this company.

## Funding rounds

- Series A, Jun 26, 2020, $13M — Johnson & Johnson Innovation, Novo Holdings, Vives, Fountain Healthcare Partners, Société Régionale d'Investissement de Wallonie, V-Bio Ventures, UCB Ventures
- Series A, Jan 24, 2018, $14M — Johnson & Johnson Innovation, Vives, Fountain Healthcare Partners, Société Régionale d'Investissement de Wallonie, UCB S.A., Novo Seeds, V-Bio Ventures

## Investors

- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series A
- Vives (https://capitalatlas.ai/funds/vives) — Series A
- Fountain Healthcare Partners (https://capitalatlas.ai/funds/fountain-healthcare-partners) — Series A
- Société Régionale d'Investissement de Wallonie — Series A
- UCB S.A. — Series A
- Novo Seeds — Series A
- V-Bio Ventures (https://capitalatlas.ai/funds/v-bio-ventures) — Series A
- Novo Holdings — Series A
- UCB Ventures (https://capitalatlas.ai/funds/ucb-ventures) — Series A